Biosceptre International's Series A Round

Biosceptre International raised a round of funding on December 15, 2017. Investors include Tuspark S & T.

Biosceptre has identified a pan-cancer target, present in many cancer types, and importantly not found in healthy tissue. Early research and initial evidence suggest that drugs directed at the nf-P2X7…

Articles about Biosceptre International's Series A Round: